HCPCS Code Q5115: Injection, Rituximab-Abbs, Biosimilar, (Truxima), 10 mg

Learn about HCPCS Code Q5115 for Rituximab-Abbs (Truxima), a biosimilar injection used to treat CD20-positive B-cell malignancies and autoimmune disorders.

Use Code

Frequently asked questions

Rituximab biosimilar treats CD20-positive B cell lymphomas including non-Hodgkin lymphoma and lymphoma unspecified, providing appropriate medical support.

Infusion related reactions can occur during intravenous push or induction infusion. Healthcare professionals provide medical support to manage these safely.

Lymph nodes including intrapelvic lymph nodes, as well as solid organ sites, influence treatment planning, requiring clinical evaluation during active disease and induction treatment.